IO Biotech, Inc.

IOBT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$60,031$143,193$142,590$211,531
Short-Term Investments$0$0$0$0
Receivables$1,133$1,127$1,533$2,091
Inventory$0$0$0$0
Other Curr. Assets$3,787$2,935$4,096$8,116
Total Curr. Assets$64,951$147,255$148,219$221,738
Property Plant & Equip (Net)$2,363$3,106$3,234$155
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$268$0$268$268
Tax Assets$0$0$0$0
Other NC Assets$117$357$84$127
Total NC Assets$2,748$3,463$3,586$550
Other Assets$0$0$0$0
Total Assets$67,699$150,718$151,805$222,288
Liabilities
Payables$4,661$3,878$4,004$3,928
Short-Term Debt$717$655$515$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$14,108$11,184$6,157$6,377
Total Curr. Liab.$19,486$15,717$10,676$10,305
LT Debt$1,198$1,839$2,275$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$59
Total NC Liab.$1,198$1,839$2,275$59
Other Liabilities$0$0$0$0
Cap. Leases$1,915$2,494$2,275$0
Total Liabilities$20,684$17,556$12,951$10,364
Equity
Pref Stock$0$0$0$0
Common Stock$66$66$29$29
Retained Earnings-$359,313-$263,822-$177,739-$106,281
AOCI-$6,851-$9,669-$10,141-$1,489
Other Equity$413,113$406,587$326,705$319,665
Total Equity$47,015$133,162$138,854$211,924
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$67,699$150,718$151,805$222,288
Net Debt-$58,116-$140,699-$139,800-$211,531